Dr. Reddy's launches generic Kuvan

Sandra Levy
Senior Editor
Sandra Levy profile picture

 Dr. Reddy’s is introducing generic Kuvan (sapropterin dihydrochloride tablets). 

“We are pleased to launch this generic version of sapropterin dihydrochloride tablets, for oral use, illustrating our continued commitment to bring affordable generic medicines to market for patients,” said Marc Kikuchi, Dr. Reddy's CEO of North America Generics. “At the same time, this product demonstrates that we are actively expanding the breadth of our portfolio with a treatment for a rare disease.  We are pleased to provide financial support to patients by offering a co-pay card program for eligible patients, details will be available on our website.”

Dr. Reddy’s generic sapropterin dihydrochloride tablets come in a dosage strength of 100 mg in 120-count bottles.